High-Dosage Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A: Results of a Randomized, Double-Masked, Controlled Trial

Overview of attention for article published in JAMA Neurology, August 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 10 X users
patent: 3 patents

facebook: 3 Facebook pages

Readers on

mendeley: 113 Mendeley

So far, Altmetric has seen 12 X posts from 10 X users, with an upper bound of 99,699 followers.

There's also https://t.co/QGwkwMtdR9 https://t.co/gqSEs301Ep https://t.co/fPwjvcnoyC also look into orthomolecular medicine (which is a AMA practice) if there's supposedly no cure & again your open, then you have nothing to lose. Hope this puts yo…

RT @jamaneuro: Does 4-g/d AA improve the #neuropathy of subjects with #CMT1A? http://t.co/ERxlJ0mpi4 c. @AllisonTMoore @CMTNeuropathy

Does 4-g/d AA improve the #neuropathy of subjects with #CMT1A? http://t.co/BSlf7TW3Xk

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.